US Patent Issued to Disc Medicine on Sept. 1 for "Methods of treating erythropoietic protoporphyria, x-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitors" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,847, issued on Sept. 1, was assigned to Disc Medicine Inc. (Watertown, Mass.).

"Methods of treating erythropoietic protoporphyria, x-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitors" was invented by Brian Richard MacDonald (Watertown, Mass.), Maria Gabriela Beconi (Watertown, Mass.) and Vu Hong (Watertown, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present embodiments are directed to methods of using glycine transporter inhibitors, such as GlyT1 inhibitors, or pharmaceutically acceptable salts, solvates or prodrugs thereof, or pharmaceutical compositions thereof, for preventing or treating...